---
layout: post
title: Novavax的新冠疫苗在英国获批用于青少年
date: 2022-08-27 11:33:02.000000000 +08:00
link: https://cn.wsj.com/amp/articles/novavax%E7%9A%84%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E5%9C%A8%E8%8B%B1%E5%9B%BD%E8%8E%B7%E6%89%B9%E7%94%A8%E4%BA%8E%E9%9D%92%E5%B0%91%E5%B9%B4-11661563806
categories: wsj
---

<main id="main" role="main">
<div>


</div>
<div itemprop="articleLead" data-sbId="CN-BIZ-20220827092409">
    <div>
      <div class="media-object scope-
          header
">
          <figure>
      <div>
        <img
          srcset="https://images.wsj.net/im-558045?width=540&amp;size=1.5005861664712778 540w, https://images.wsj.net/im-558045?width=620&amp;size=1.5005861664712778 620w, https://images.wsj.net/im-558045?width=639&amp;size=1.5005861664712778 639w, https://images.wsj.net/im-558045?width=860&amp;size=1.5005861664712778 860w, https://images.wsj.net/im-558045?width=860&amp;size=1.5005861664712778&amp;pixel_ratio=1.5 1290w, https://images.wsj.net/im-558045?width=860&amp;size=1.5005861664712778&amp;pixel_ratio=2 1720w, https://images.wsj.net/im-558045?width=860&amp;size=1.5005861664712778&amp;pixel_ratio=3 2580w"
          src="https://images.wsj.net/im-558045?width=860&amp;height=573"
          layout="responsive"
          placeholder
          alt="">
        </img>
      </div>
      <figcaption>
        <p> 图片来源：MARKUS HIBBELER/ZUMA PRESS</p>
  </figcaption>
</figure>

      </div>
    </div>
</div>
<div data-sbId="CN-BIZ-20220827092409">

<div>

  <div>
      <p> </p>
              <p><span itemprop="name">
                <a href="https://www.wsj.com/news/author/dean-seal" itemprop="url" rel="author">Dean Seal</a>
              </span></p>

  </div>
    <time>
      2022年8月27日09:30 CST 更新
    </time>
</div>

<div>
  <social-share type="system" width="72" height="24"
    data-param-url="https://cn.wsj.com/articles/novavax的新冠疫苗在英国获批用于青少年-11661563806">
  </social-share>
</div>


<div subscriptions-section="content">
</div>
<div subscriptions-section="content-not-granted">
</div>



<section subscriptions-section="content">
      <p>Novavax Inc. (NVAX)周五表示，其新冠疫苗已获得英国药物及保健产品规管局批准用于12至17岁的青少年。</p>
      <p>这家生物技术公司表示，在2,200多名美国青少年参与的一项临床试验取得强劲结果后，监管机构扩大了其Nuvaxovid新冠疫苗的有条件上市许可。</p>
      <p><em>（本文来自道琼斯通讯社）</em></p>
      <div></div>
</section>

</div>
      </main>
